Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 190.40B P/E 30.23 EPS this Y 0.40% Ern Qtrly Grth -25.00%
Income 4.07B Forward P/E 29.24 EPS next Y 14.10% 50D Avg Chg 7.00%
Sales 23.74B PEG 4.46 EPS past 5Y 16.66% 200D Avg Chg 3.00%
Dividend N/A Price/Book 3.68 EPS next 5Y 7.52% 52W High Chg -15.00%
Recommedations 2.10 Quick Ratio 1.34 Shares Outstanding 740.69M 52W Low Chg 17.00%
Insider Own 10.75% ROA 3.86% Shares Float 660.20M Beta 0.88
Inst Own 81.68% ROE 7.76% Shares Shorted/Prior 6.01M/6.20M Price 257.87
Gross Margin 58.89% Profit Margin 18.55% Avg. Volume 3,288,670 Target Price 272.09
Oper. Margin 23.09% Earnings Date Jul 23 Volume 2,545,214 Change 1.13%
About Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Danaher Corporation News
06/14/24 Here's Why Hold Strategy Is Apt for Danaher (DHR) Stock Now
06/13/24 Pall Corporation opens regional hub in Singapore
06/11/24 Is Danaher Corp (NYSE:DHR) the Best Undervalued Stock Pick of Billionaire Paul Tudor Jones?
06/07/24 Dan Loeb Likes this Growth Stock
06/06/24 Danaher names Martin Stumpe as chief data and AI officer
06/05/24 Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence Officer
05/23/24 Why Is Danaher (DHR) Up 6.7% Since Last Earnings Report?
05/21/24 The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: UnitedHealth, Danaher, Abbott and Ark Restaurants
05/20/24 Top Stock Reports for UnitedHealth, Danaher & Abbott
05/17/24 Insider Sale: President & CEO Rainer Blair Sells 9,005 Shares of Danaher Corp (DHR)
05/15/24 Danaher (DHR) Rides on Business Strength Amid Headwinds
05/12/24 Questor: This biotech giant is backed by the world’s best fund managers
05/09/24 Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis
05/08/24 Danaher Corporation (DHR) Is a Trending Stock: Facts to Know Before Betting on It
05/07/24 Danaher to Present at Bank of America Securities Healthcare Conference
05/07/24 Danaher Announces Quarterly Dividend
05/03/24 Markel (MKL) Q1 Earnings, Revenues Miss Estimates, Rise Y/Y
05/03/24 Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry
05/01/24 Increases to Danaher Corporation's (NYSE:DHR) CEO Compensation Might Cool off for now
04/26/24 ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside?
DHR Chatroom

User Image TaylorTwits Posted - 2 days ago

$DHR NON STOP LOWER LOWS STOCK MARKET CRASHNLIKE THE MARKET DID IN COVID COLLAPSE COLLAPSE JERRY $DJIA $PYPL $NASDAQ $QQQ

User Image rickyspanish Posted - 2 days ago

$SPY I don't even know what you do $dhr but your ass is getting shorted >=)

User Image StrayTrader Posted - 2 days ago

$DHR Hedge fund BS games sometimes give us an opportunity. Big decline here on no particularly relevant news. Loading calls.

User Image mrval88 Posted - 2 days ago

$DHR

User Image hectorasilvac Posted - 3 days ago

$DHR This company is struggling to overcome last week's high; we can see a sort of rejection in the monthly bar. It doesn't have a catalyst, but it also doesn't have any good news, so I'll follow the technicals. There's a significant short interest.

User Image StockInvest_us Posted - 5 days ago

Signal alert: $DHR - Double Top https://stockinvest.us/l/VNIXIoxfRh

User Image MSInvestments Posted - 1 week ago

$AXP $DHR CNBC just mentioned that AXP is the top DOW performer for the year 👍🏼 and made me think of the criticism to the posted move at the time. Since the reduction the capital was moved after looking at potential opportunities into DHR which was the next day. Since then the results are obvious... Not a rub but rather just to provide feedback. Bullish on both positions and it could have been a negative outcome (sometimes it is). Just not this time.

User Image Righon23420 Posted - 05/31/24

$MASS this look like a prime acquisition candidate. $tmo $DHR

User Image Nosh Posted - 05/30/24

$CWCO $MSEX $LIN $ECL Added...$DHR because it use to trade with this group but also adding their environmental arm. GLTY.

User Image StockInvest_us Posted - 05/28/24

Signal alert: $DHR - Overbought Trend Short (Overvalued) https://stockinvest.us/l/BVVj4xOZGz

User Image satsandstocks Posted - 05/22/24

$DHR WEEKLY - JUL 19 - 290C - 1.35 LOOKS INTERESTING

User Image StrayTrader Posted - 05/22/24

$DHR trading at an extremely expensive valuation, but it’s currently a darling in a favored sector, so it gets a pass. Sooner or later, there will be a rug pull, just as there always is.

User Image QuiverQuant Posted - 05/21/24

CONGRESSIONAL TRADING: Senator Whitehouse, Sheldon disclosed a sale (full) of $15,001 - $50,000 of $DHR on 2024-05-20.

User Image RNAlivesmatter Posted - 05/21/24

$DHR should follow sector up

User Image lextrading Posted - 05/19/24

$DHR The stock is breaking out of 2 supporting trendlines. One of which is a key supporting trendline that has been buyers step in 9x since 2012. See the charts on my Substack: https://open.substack.com/pub/kxuongle/p/danaher-corporations-key-support?r=2bgp9u&utm_campaign=post&utm_medium=web

User Image thayford Posted - 05/17/24

$DHR +13.5%

User Image InsiderPeek Posted - 05/17/24

$DHR CEO Blair Rainer sold 9k shares for $2.4 millions (ownership down 7.76%) insiderpeek.com/company/DHR

User Image StrayTrader Posted - 1 month ago

$DHR how much is enough? 44x earnings? Is that enough?

User Image JFDI Posted - 1 month ago

$DHR Speaking my language!

User Image SilverEagle Posted - 1 month ago

$DHR 👀 over 270?

User Image Comicguy Posted - 1 month ago

$DHR https://www.reuters.com/markets/deals/novo-nordisk-owner-buys-majority-stake-austrian-life-science-tools-company-2024-05-15/

User Image PFRunRateCashAdjEBITDA Posted - 1 month ago

$CR just tuned into the entire $CR analyst day event - headed in right direction. Outstanding management. I am as convinced as ever this is the next $DHR $WSO

User Image Stock_Titan Posted - 1 month ago

$DHR Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis https://www.stocktitan.net/news/DHR/danaher-launches-collaboration-with-johns-hopkins-university-aiming-v6xmrim4dfqd.html

User Image UncleStock Posted - 1 month ago

$RGLD $AMRK $DHR suggested for #preciousmetals - value screen: https://zpr.io/gQdAr

User Image Righon23420 Posted - 1 month ago

$DNA biotech showed a nice recovery in Q1 after a terrible 2023. DNA has dropped too far. $TMO and $DHR, the Amazon and walmart of biotech, beat revenue projections in Q1.

User Image UncleStock Posted - 1 month ago

$RGLD $AMRK $DHR suggested for #preciousmetals - value screen: https://zpr.io/gQdAr

User Image JonnyArcade Posted - 1 month ago

$UNH $DHR $TMO is it me or did all of these gap up and form a bull flag? 🤔 Call options on UNH seem to be the best R/R

User Image Stock_Titan Posted - 1 month ago

$DHR Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry https://www.stocktitan.net/news/DHR/curiox-biosystems-and-beckman-coulter-life-sciences-announce-a-lnbkxxo5y2yr.html

User Image green_going_up Posted - 1 month ago

$DNA low valuation increases the likelihood of some type of M&A buyout transaction IMO; a Blackstone Lifesciences, for example, is a Private Equity firm that can certainly run detailed models using probabilities of downstream economics to estimate future cash flows; meanwhile $TMO, $DHR, $A, $TECH and other lifescience tooling firms would love to have Gingko's pipeline for client services and Ginkgo's platform to add to their platforms to enhance tooling, R&D services.

User Image WallStJesus Posted - 04/30/24

SOME NAMES SEEING BULL FLOW TODAY INCLUDE: $STX $LUV $DHR $DXCM $GD & SPECS ACTIVE IN THE #WEED PLAYS OFF A HEADLINE -- OVERALL FLOW IN NAMES A BEARISH LEAN TO THIS POINT DOMINATED BY EARNINGS PROTECTION

Analyst Ratings
Citigroup Buy Apr 24, 24
TD Cowen Buy Apr 24, 24
B of A Securities Neutral Apr 24, 24
Barclays Equal-Weight Apr 24, 24
Baird Outperform Apr 24, 24
HSBC Buy Apr 17, 24
Barclays Equal-Weight Apr 10, 24
Keybanc Overweight Feb 1, 24
Citigroup Buy Jan 31, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Gutierrez-Ramos Jose-Carlos SVP, Chief Science O.. SVP, Chief Science Officer Aug 21 Sell 250.54 590 147,819 6,939 08/22/23
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Jul 26 Sell 263.42 22,439 5,910,881 88,689 07/27/23
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Jul 26 Option 56.7 22,439 1,272,291 111,128 07/27/23
List Teri Director Director Jul 26 Sell 263.3 3,490 918,917 17,494 07/27/23
List Teri Director Director Jul 26 Option 50.8 3,490 177,292 20,984 07/27/23
Raskas Daniel SVP - Corporate Deve.. SVP - Corporate Development May 31 Sell 228.5 19,847 4,535,040 38,673 06/01/23
Raskas Daniel SVP - Corporate Deve.. SVP - Corporate Development May 31 Option 57.9 19,847 1,149,141 58,520 06/01/23
LOHR WALTER G Director Director May 05 Sell 240.88 3,490 840,671 12,115 05/08/23
LOHR WALTER G Director Director May 05 Option 50.8 3,490 177,292 15,605 05/08/23
Couchara Georgeann SVP, Human Resources SVP, Human Resources Nov 15 Sell 271.61 1,884 511,713 2,588 11/16/22
McGrew Matthew EVP & Chief Financia.. EVP & Chief Financial Officer Nov 11 Option 57.3 18,935 1,084,976 40,847 11/14/22
McGrew Matthew EVP & Chief Financia.. EVP & Chief Financial Officer Nov 11 Sell 274.67 18,935 5,200,876 29,634 11/14/22
Honeycutt Jennifer Executive Vice Presi.. Executive Vice President Nov 10 Option 65.83 8,211 540,530 15,373 11/14/22
Honeycutt Jennifer Executive Vice Presi.. Executive Vice President Nov 10 Sell 265 8,211 2,175,915 7,162 11/14/22
Blair Rainer President & CEO President & CEO Aug 15 Option 68.29 25,000 1,707,250 104,739 08/17/22
Blair Rainer President & CEO President & CEO Aug 15 Sell 300 25,000 7,500,000 79,739 08/17/22
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Jul 25 Sell 271.56 12,000 3,258,720 74,398 07/26/22
LOHR WALTER G Director Director Jul 22 Option 38.64 4,548 175,735 16,663 07/25/22
LOHR WALTER G Director Director Jul 22 Sell 273.84 3,906 1,069,619 12,115 07/25/22
SCHWIETERS JOHN T Director Director Jul 13 Option 38.64 4,548 175,735 18,663 07/14/22
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Apr 25 Sell 255.735 6,500 1,662,278 86,398 04/27/22
Ellis Brian W Senior Vice Presiden.. Senior Vice President - GC Feb 02 Sell 293.9884 5,365 1,577,248 12,374 02/03/22
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Jan 31 Option 46.13 20,508 946,034 84,351 02/02/22
Weidemanis Joakim Executive Vice Presi.. Executive Vice President Jan 31 Sell 285.24 20,508 5,849,702 63,843 02/02/22
RALES MITCHELL P Chairman of Exec. Co.. Chairman of Exec. Committee Nov 02 Sell 308.71 1,225,841 378,429,375 11/04/21
LUTZ ROBERT S SVP-Chief Accounting.. SVP-Chief Accounting Officer Oct 27 Option 46.13 24,594 1,134,521 43,544 10/27/20
LUTZ ROBERT S SVP-Chief Accounting.. SVP-Chief Accounting Officer Oct 27 Sell 234.37 24,594 5,764,096 18,950 10/27/20
COMAS DANIEL L EVP EVP Oct 27 Option 65.83 54,402 3,581,284 109,607 10/27/20
COMAS DANIEL L EVP EVP Oct 27 Sell 233.99 54,402 12,729,524 92,683 10/27/20